Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients

Theranostics

6 June Jun 2019 6 years ago
  • Rurali E, Perrucci GL, Moschetta D, Nigro P, Pompilio
QR Code

Marfan syndrome (MFS) is a rare genetic disease characterized by a matrix metalloproteases (MMPs) dysregulation that leads to extracellular matrix degradation. Consequently, MFS patients are prone to develop progressive thoracic aortic enlargement and detrimental aneurysm. Since MMPs are activated by the extracellular MMP inducer (EMMPRIN) protein, we determined whether its plasmatic soluble form (sEMMPRIN) may be considered a marker of thoracic aortic ectasia (AE).

Reference

Rurali E, Perrucci GL, Gaetano R, Pini A, Moschetta D, Gentilini D, Nigro P, Pompilio G. Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients. Theranostics 2019 Apr 12;9(8):2224-2234. doi: 10.7150/thno.30714.

Go to PubMed